Results 11 to 20 of about 891,540 (202)

Novel Treatments in Refractory Recurrent Pericarditis [PDF]

Pharmaceuticals
Refractory recurrent pericarditis is a troublesome condition that severely impairs the quality of life of affected patients and significantly increases healthcare spending.
Emilia Lazarou, Christos Koutsianas, Panayotis K. Vlachakis, Panagiotis Theofilis, Dimitrios Vassilopoulos, Costas Tsioufis, George Lazaros, Dimitris Tousoulis   +7 more
doaj   +5 more sources

Comparative Efficacy and Safety of Colchicine and Anti–Interleukin‐1 Agents in Recurrent Pericarditis: A Pairwise and Network Meta‐Analysis of Randomized Controlled Trials [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background The management of recurrent pericarditis includes colchicine and anti–interleukin‐1 agents, given the limited efficacy and adverse effects of NSAIDs and corticosteroids.
Muhammad Ehsan, Alveena Batool Syed, Biah Mustafa, Jibran Ikram, Muhammad Hammad Khan, Paul C. Cremer, Massimo Imazio, Tom Kai Ming Wang, Allan L. Klein   +8 more
doaj   +3 more sources

Autoinflammatory Recurrent Pericarditis Associated with a New NLRP12 Mutation in a Male Adolescent [PDF]

Life, 2023
Idiopathic recurrent pericarditis (IRP) can be the hallmark of an autoinflammatory syndrome with recurrent attacks of chest pain and symptom-free intervals following an acute episode. The recurrence rate may be 35% in the pediatric population, frequently
Eliza Cinteza, Dan Stefan, Mihaela Adela Iancu, Andreea Ioan, Corina Maria Vasile, Radu Vatasescu, Alexis Cochino   +6 more
doaj   +3 more sources

Interleukin-1 Blockers: A Paradigm Shift in the Treatment of Recurrent Pericarditis [PDF]

Life
Recurrent pericarditis is a problematic clinical condition that impairs the quality of life of the affected patients due to the need for repeated hospital admissions, emergency department visits, and complications from medications, especially ...
Emilia Lazarou, Christos Koutsianas, Panagiotis Theofilis, George Lazaros, Dimitrios Vassilopoulos, Charalambos Vlachopoulos, Costas Tsioufis, Massimo Imazio, Antonio Brucato, Dimitris Tousoulis   +9 more
doaj   +3 more sources

A Rare Cause of Recurrent Pericarditis. [PDF]

Cureus
Recurrent pericarditis poses a significant challenge to clinicians, particularly when patients are unresponsive or intolerant to conventional treatments.
Aletras G, Stratinaki M, Bachlitzanaki M, Georgopoulou T, Foukarakis EG.   +4 more
europepmc   +4 more sources

IL-1 Receptor Antagonist Antibodies in Idiopathic Recurrent Pericarditis. [PDF]

JAMA Netw Open
This cohort study investigates the prevalence and role of autoantibodies targeting the endogenous interleukin 1 (IL-1) receptor antagonist in patients with recurrent pericarditis with an inflammatory phenotype.
Wu MA, Kessel C, Fadle N, Regitz E, Fuehner S, Negro E, Berra S, Pfeifer J, Ceriani E, Thurner B, Klingel K, Caforio A, Imazio M, Brucato A, Thurner L.   +14 more
europepmc   +2 more sources

Current Drug Treatment for Acute and Recurrent Pericarditis. [PDF]

Drugs
Pericarditis is the most frequent pericardial disease and presents with a relatively benign course when treated according to guideline-directed therapies at first presentation.
Bonaventura A, Santagata D, Vecchié A, Abbate A.   +3 more
europepmc   +2 more sources

Tolicizumab: a new option for refractory idiopathic recurrent pericarditis: a case report. [PDF]

Eur Heart J Case Rep
Background Recurrent pericarditis is the most common and troublesome complication of pericarditis and can be particularly challenging when it becomes refractory to conventional therapies, often resulting in a prolonged disease course. Interleukin-1 (IL-1)
Collini V, Venturelli F, Quinzani F, Sappa R, Imazio M.   +4 more
europepmc   +2 more sources

Sex related differences in acute and recurrent pericarditis: A narrative review [PDF]

American Heart Journal Plus
Background: Acute and recurrent pericarditis represent significant clinical challenges, with growing evidence suggesting important sex-related differences in their presentation, etiology, and course.
Nouf Alanazi
doaj   +2 more sources

Interleukin-1 Inhibitors for Management of Recurrent Pericarditis After Thoracic Organ Transplantation. [PDF]

JACC Case Rep
There is a growing body of evidence supporting the safety and utility of interleukin-1 inhibitors for treatment of recurrent pericarditis. This therapy has not been investigated specifically as related to postpericardiotomy syndrome or after thoracic ...
Rajput B, Singh A, Garshick MS.
europepmc   +2 more sources